Nifty
Sensex
:
:
18696.10
62868.50
-116.40 (-0.62%)
-415.69 (-0.66%)

Chemicals

Rating :
35/99

BSE: 530019 | NSE: JUBLPHARMA

381.15
01-Dec-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 391.55
  • 391.75
  • 380.10
  • 391.55
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  146845
  •  562.78
  •  614.35
  •  281.80

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 6,084.54
  • 37.31
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 8,027.92
  • 1.31%
  • 1.11

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 50.68%
  • 2.85%
  • 19.00%
  • FII
  • DII
  • Others
  • 23.06%
  • 0.39%
  • 4.02%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.73
  • -4.00
  • -12.51

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 0.80
  • -5.30
  • -9.90

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.75
  • -7.99
  • -22.14

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.71
  • 14.35
  • 13.91

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.11
  • 2.02
  • 1.71

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.67
  • 8.01
  • 7.50

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 22
Sep 21
Var%
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Net Sales
1,599.50
1,657.45
-3.50%
1,451.72
1,634.65
-11.19%
1,527.53
1,579.78
-3.31%
1,310.53
1,771.34
-26.01%
Expenses
1,380.75
1,317.95
4.76%
1,259.32
1,259.41
-0.01%
1,280.18
1,205.16
6.22%
1,116.29
1,278.58
-12.69%
EBITDA
218.75
339.50
-35.57%
192.40
375.24
-48.73%
247.35
374.62
-33.97%
194.24
492.76
-60.58%
EBIDTM
13.68%
20.48%
13.25%
22.96%
16.19%
23.71%
14.82%
27.82%
Other Income
13.10
4.45
194.38%
11.31
3.89
190.75%
-2.96
6.69
-
5.91
3.59
64.62%
Interest
42.02
34.74
20.96%
39.93
34.62
15.34%
39.51
43.34
-8.84%
36.62
46.37
-21.03%
Depreciation
93.95
99.78
-5.84%
94.57
88.04
7.42%
100.55
86.24
16.59%
93.33
95.94
-2.72%
PBT
39.06
209.43
-81.35%
69.21
256.47
-73.01%
104.33
241.39
-56.78%
70.20
343.15
-79.54%
Tax
31.48
65.40
-51.87%
22.31
86.02
-74.06%
46.58
83.06
-43.92%
19.43
121.16
-83.96%
PAT
7.58
144.03
-94.74%
46.90
170.45
-72.48%
57.75
158.33
-63.53%
50.77
221.99
-77.13%
PATM
0.47%
8.69%
3.23%
10.43%
3.78%
10.02%
3.87%
12.53%
EPS
0.34
8.97
-96.21%
2.95
10.09
-70.76%
3.74
13.44
-72.17%
3.20
19.46
-83.56%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
5,889.28
6,130.16
6,098.53
9,154.41
9,110.82
7,517.84
5,861.43
5,749.13
5,826.25
5,803.36
5,165.95
Net Sales Growth
-11.35%
0.52%
-33.38%
0.48%
21.19%
28.26%
1.95%
-1.32%
0.39%
12.34%
 
Cost Of Goods Sold
1,558.26
1,488.01
1,536.01
3,140.58
3,521.84
2,862.51
2,002.74
2,116.20
2,663.02
2,438.46
2,062.85
Gross Profit
4,331.02
4,642.16
4,562.52
6,013.84
5,588.98
4,655.33
3,858.69
3,632.94
3,163.23
3,364.90
3,103.10
GP Margin
73.54%
75.73%
74.81%
65.69%
61.34%
61.92%
65.83%
63.19%
54.29%
57.98%
60.07%
Total Expenditure
5,036.54
4,973.83
4,702.07
7,207.34
7,371.81
5,999.45
4,516.14
4,502.19
5,124.71
4,782.37
4,097.81
Power & Fuel Cost
-
134.30
105.79
112.21
466.38
424.91
333.66
366.71
393.04
389.74
356.73
% Of Sales
-
2.19%
1.73%
1.23%
5.12%
5.65%
5.69%
6.38%
6.75%
6.72%
6.91%
Employee Cost
-
2,043.39
1,922.88
2,127.68
1,925.96
1,555.88
1,230.93
1,125.09
1,090.28
1,105.17
962.58
% Of Sales
-
33.33%
31.53%
23.24%
21.14%
20.70%
21.00%
19.57%
18.71%
19.04%
18.63%
Manufacturing Exp.
-
562.32
449.40
362.15
552.26
485.98
428.84
436.46
432.40
405.14
360.48
% Of Sales
-
9.17%
7.37%
3.96%
6.06%
6.46%
7.32%
7.59%
7.42%
6.98%
6.98%
General & Admin Exp.
-
432.34
387.92
416.80
540.75
354.56
280.98
256.23
302.28
264.23
208.35
% Of Sales
-
7.05%
6.36%
4.55%
5.94%
4.72%
4.79%
4.46%
5.19%
4.55%
4.03%
Selling & Distn. Exp.
-
209.71
177.15
194.71
267.70
247.85
185.79
135.54
203.98
160.04
123.28
% Of Sales
-
3.42%
2.90%
2.13%
2.94%
3.30%
3.17%
2.36%
3.50%
2.76%
2.39%
Miscellaneous Exp.
-
103.77
122.93
853.22
96.92
67.76
53.20
65.96
39.72
19.59
123.28
% Of Sales
-
1.69%
2.02%
9.32%
1.06%
0.90%
0.91%
1.15%
0.68%
0.34%
0.46%
EBITDA
852.74
1,156.33
1,396.46
1,947.07
1,739.01
1,518.39
1,345.29
1,246.94
701.54
1,020.99
1,068.14
EBITDA Margin
14.48%
18.86%
22.90%
21.27%
19.09%
20.20%
22.95%
21.69%
12.04%
17.59%
20.68%
Other Income
27.36
11.29
17.64
47.43
35.74
40.03
24.86
13.37
42.45
19.06
29.87
Interest
158.08
145.49
184.10
287.41
219.81
284.28
341.11
371.35
367.61
337.11
310.93
Depreciation
382.40
381.70
348.95
461.93
370.90
415.05
291.40
346.74
287.95
281.17
253.79
PBT
282.80
640.43
881.05
1,245.17
1,184.04
859.08
737.64
542.22
88.43
421.78
533.29
Tax
119.80
217.43
297.22
312.29
326.80
224.66
163.02
155.40
80.48
69.64
152.36
Tax Rate
42.36%
33.95%
34.57%
25.80%
36.16%
26.15%
22.10%
28.66%
199.55%
33.60%
44.66%
PAT
163.00
423.92
562.87
898.24
574.46
642.81
575.66
391.83
-57.76
109.04
152.73
PAT before Minority Interest
164.51
423.00
562.61
898.24
577.01
634.42
574.63
386.82
-40.16
137.64
188.78
Minority Interest
1.51
0.92
0.26
0.00
-2.55
8.39
1.03
5.01
-17.60
-28.60
-36.05
PAT Margin
2.77%
6.92%
9.23%
9.81%
6.31%
8.55%
9.82%
6.82%
-0.99%
1.88%
2.96%
PAT Growth
-76.54%
-24.69%
-37.34%
56.36%
-10.63%
11.66%
46.92%
-
-
-28.61%
 
EPS
10.23
26.61
35.33
56.39
36.06
40.35
36.14
24.60
-3.63
6.84
9.59

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
5,318.56
4,741.49
5,603.88
4,808.92
4,086.53
3,436.04
2,966.26
2,453.52
2,626.51
2,476.12
Share Capital
15.92
15.92
15.93
15.93
15.58
15.57
15.54
15.93
15.45
15.93
Total Reserves
5,298.98
4,724.75
5,587.95
4,792.94
4,070.78
3,419.98
2,950.72
2,437.59
2,611.07
2,460.19
Non-Current Liabilities
2,921.59
2,973.05
4,087.52
4,420.21
3,417.47
3,826.06
3,347.13
4,036.15
2,184.95
3,004.85
Secured Loans
200.94
20.78
728.92
811.65
729.88
1,581.96
2,620.41
3,316.29
1,716.67
1,708.74
Unsecured Loans
2,263.30
2,543.19
3,010.76
3,431.24
2,317.93
1,923.07
392.79
375.00
0.22
760.06
Long Term Provisions
95.67
94.01
150.75
114.35
107.08
80.69
70.31
67.04
219.53
237.96
Current Liabilities
1,591.60
1,048.83
2,619.01
2,089.73
2,004.69
1,684.04
2,464.44
2,129.16
3,894.41
2,778.35
Trade Payables
567.74
520.48
1,090.27
1,020.13
1,136.16
749.49
612.12
721.19
718.14
647.13
Other Current Liabilities
838.52
371.73
674.21
473.57
505.87
572.70
951.43
793.31
1,731.20
898.00
Short Term Borrowings
64.00
20.00
649.89
499.71
244.85
255.60
748.97
517.17
1,187.83
1,131.39
Short Term Provisions
121.34
136.62
204.64
96.31
117.81
106.24
151.93
97.49
257.25
101.84
Total Liabilities
9,829.59
8,763.40
12,310.41
11,318.96
9,457.17
8,898.75
8,739.70
8,618.83
8,863.81
8,370.86
Net Block
4,870.61
4,608.75
6,339.97
5,648.38
5,400.55
5,106.73
5,104.42
4,911.33
5,098.78
4,967.46
Gross Block
6,691.97
6,089.57
7,982.83
6,905.50
6,288.86
5,672.38
5,390.82
7,362.10
7,330.63
6,870.15
Accumulated Depreciation
1,821.36
1,480.83
1,642.85
1,257.12
888.31
565.66
286.40
2,450.76
2,231.85
1,902.69
Non Current Assets
6,320.40
5,810.90
7,272.06
6,734.16
6,267.41
5,950.63
5,864.37
5,904.29
5,935.78
5,809.80
Capital Work in Progress
1,089.57
896.99
768.39
901.43
670.97
683.78
611.32
596.60
472.39
436.89
Non Current Investment
238.60
240.96
69.36
115.11
123.52
102.71
85.43
39.50
33.99
25.61
Long Term Loans & Adv.
117.64
62.84
86.81
68.59
71.79
56.32
62.67
327.17
328.42
379.47
Other Non Current Assets
3.98
1.35
7.53
0.66
0.58
1.08
0.53
29.68
2.21
0.37
Current Assets
3,509.19
2,952.50
5,038.35
4,584.80
3,189.76
2,948.12
2,875.32
2,714.54
2,928.03
2,561.06
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1,254.87
1,129.38
1,845.38
1,417.39
1,391.39
1,220.40
1,203.10
1,235.33
1,341.42
1,116.18
Sundry Debtors
927.99
819.90
1,293.22
1,271.55
1,130.76
1,005.30
950.50
819.27
805.87
708.54
Cash & Bank
984.24
671.32
1,399.87
1,370.41
248.79
459.63
344.58
394.34
479.53
356.05
Other Current Assets
342.09
242.37
419.59
485.64
418.81
262.79
377.13
265.59
301.21
380.29
Short Term Loans & Adv.
100.53
89.53
80.29
39.80
45.75
37.06
133.06
144.56
136.04
182.01
Net Current Assets
1,917.59
1,903.67
2,419.34
2,495.07
1,185.06
1,264.08
410.88
585.38
-966.38
-217.29
Total Assets
9,829.59
8,763.40
12,310.41
11,318.96
9,457.17
8,898.75
8,739.69
8,618.83
8,863.81
8,370.86

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
837.54
1,784.27
1,542.94
1,121.51
1,303.20
1,268.49
1,098.89
783.26
772.27
969.90
PBT
630.45
1,212.01
1,210.53
903.81
859.08
737.64
542.22
40.32
207.28
341.14
Adjustment
579.47
716.48
760.74
861.53
687.81
637.90
737.89
725.84
756.60
752.36
Changes in Working Capital
-178.29
249.90
-179.67
-300.53
14.15
36.88
-133.16
96.40
-110.70
-4.04
Cash after chg. in Working capital
1,031.63
2,178.39
1,791.60
1,464.82
1,561.04
1,412.42
1,146.96
862.57
853.18
1,089.46
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-194.09
-394.12
-248.66
-343.31
-257.84
-143.94
-48.07
-79.31
-80.91
-119.56
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-380.37
-739.01
-327.00
-1,011.84
-617.70
-450.39
-312.53
-343.33
-174.42
-499.72
Net Fixed Assets
0.99
2,198.22
-241.66
-305.67
-147.58
-115.33
785.60
1,162.43
-166.96
-286.05
Net Investments
0.23
118.05
-0.14
-57.59
3.34
-0.39
57.01
239.81
-27.56
-18.79
Others
-381.59
-3,055.28
-85.20
-648.58
-473.46
-334.67
-1,155.14
-1,745.57
20.10
-194.88
Cash from Financing Activity
-32.60
-1,709.39
-1,050.37
657.43
-901.13
-685.87
-842.75
-502.69
-414.41
-449.76
Net Cash Inflow / Outflow
424.57
-664.13
165.56
767.10
-215.63
132.22
-56.38
-62.76
183.44
20.41
Opening Cash & Equivalents
501.96
1,230.81
1,005.40
244.18
456.44
339.27
391.64
473.49
279.65
263.08
Closing Cash & Equivalent
983.82
501.96
1,230.81
1,005.40
244.18
456.44
339.27
391.63
473.49
279.65

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
333.91
297.84
351.83
301.93
262.33
220.61
190.90
154.04
170.07
155.46
ROA
4.55%
5.34%
7.60%
5.55%
6.91%
6.52%
4.46%
-0.46%
1.60%
2.34%
ROE
8.41%
10.88%
17.25%
12.97%
16.87%
17.95%
14.27%
-1.58%
5.39%
7.98%
ROCE
10.09%
11.89%
15.07%
13.06%
15.21%
14.44%
12.42%
5.72%
7.92%
10.19%
Fixed Asset Turnover
0.96
0.87
1.23
1.38
1.26
1.09
0.92
0.81
0.84
0.82
Receivable days
52.04
63.24
51.13
48.12
51.58
59.43
54.81
49.56
46.53
47.00
Inventory Days
70.98
89.02
65.05
56.26
63.07
73.64
75.51
78.58
75.51
73.76
Payable days
133.47
191.38
58.75
55.42
56.86
54.84
53.44
52.17
51.42
45.33
Cash Conversion Cycle
-10.45
-39.12
57.43
48.96
57.79
78.23
76.88
75.98
70.61
75.42
Total Debt/Equity
0.55
0.55
0.83
1.01
0.85
1.18
1.51
1.95
1.67
1.71
Interest Cover
5.40
5.67
5.21
5.11
4.02
3.16
2.46
1.11
1.61
2.10

News Update:


  • Jubilant Pharmova - Quarterly Results
    21st Oct 2022, 13:44 PM

    Read More
  • Jubilant Pharmova’s arm gets EIR from USFDA for radiopharmaceuticals manufacturing facility Montreal Canada
    27th Aug 2022, 10:06 AM

    With the receipt of the EIR, the inspection stands successfully closed

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.